Accelerate Diagnostics (AXDX) Posts Smaller Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts AXDX Hot Sheet
Join SI Premium – FREE
Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.9 million.
Net cash used in the quarter was $13.2 million, and the company ended the quarter with total cash, investments, and cash equivalents of $50.4 million.
For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- QNB Corp. (QNBC) Reports Q3 Loss of $1.30
- Home Federal Bancorp of Louisiana (HFBL) Tops Q3 EPS by 64c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
